AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Abundant Produce

0.027

0.000

Volume:- -

Turnover:150.33K

Market Cap:2.29M

PE:- -

High:0.027

Open:0.027

Low:0.027

Close:0.027

52wk High:0.027

52wk Low:0.027

Shares:84.85M

Float Shares:39.30M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Abbott Laboratories Signs Supply, Distribution Deal With Avricore Health's HealthTab Unit

MT Newswires Live

Abbott Laboratories (ABT) Just Gave Investors Something To Think About

Simply Wall St.

Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment

MT Newswires Live

Abbott Stock And 2 Dividend Ideas For Retirement Income

Simply Wall St.

Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says

MT Newswires Live

GUIDANCE: (ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.45 to $5.60, vs. FactSet Est of $5.47

MT Newswires Live

3 US Healthcare Stocks Investors May Revisit As Inflation Pressures Build

Simply Wall St.

S&P 500 Posts Weekly Gain as Technology, Energy Rally

MT Newswires Live

How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott (ABT) Has Changed Its Investment Story

Simply Wall St.

Abbott Laboratories, ALZpath Sign Global Licensing Deal for Alzheimer's Disease Diagnostic

MT Newswires Live

Abbott Laboratories (ABT) Stock After 33% One-Year Slide Is The Market Overreacting

Simply Wall St.

Abbott Laboratories (ABT) Stock Could Be 24% Below Fair Value Before Earnings

Simply Wall St.

Abbott Laboratories (ABT) Is Up 6.4% After European Approval of Dual Glucose‑Ketone Sensors

Simply Wall St.

Insulet Rolls Out Omnipod 5 With Enhanced Algorithm, Abbott Libre 3 Plus Compatibility

MT Newswires Live

Is Abbott Laboratories (ABT) Now Attractive After A 33% One Year Share Price Slide

Simply Wall St.

Assessing Abbott Laboratories (ABT) Valuation After Nutrition Setbacks Legal Uncertainty And Softer Analyst Sentiment

Simply Wall St.

Exact Sciences Deal and Legal Pressures Might Change The Case For Investing In Abbott (ABT)

Simply Wall St.

Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase

MT Newswires Live

Assessing Abbott (ABT) Valuation After New Cardiac Trial Results And Recent Share Price Pullback

Simply Wall St.

Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ABT.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ABT.AU\",,,,,undefined,":{"symbol":"ABT.AU","market":"AU","secType":"STK","nameCN":"Abundant Produce","latestPrice":0.027,"timestamp":1787292000000,"preClose":0.027,"halted":3,"volume":0,"delay":0,"changeRate":0,"nameEN":"Abundant Produce","floatShares":39299635,"shares":84848333,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"08-21 16:00:00 AEST","open":0.027,"high":0.027,"low":0.027,"amount":150332.332916766,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.027,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ABT.AU\",,,,,undefined,":{"symbol":"ABT.AU","floatShares":39299635,"roa":"--","roe":"--","lyrEps":0,"shares":84848333,"dividePrice":0,"high":0.027,"amplitude":0,"preClose":0.027,"low":0.027,"week52Low":0.027,"pbRate":"--","week52High":0.027,"institutionHeld":0,"latestPrice":0.027,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.027},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABT.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABT.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660285771","title":"Abbott Laboratories Signs Supply, Distribution Deal With Avricore Health's HealthTab Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2660285771","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660285771?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:53","pubTimestamp":1787223185,"startTime":"0","endTime":"0","summary":"Abbott Laboratories  signed a multi-year collaboration deal with Avricore Health's HealthTab unit for the supply and distribution of Abbott's point-of-care testing products via the HealthTab platform in the UK, according to a Thursday statement.No financial details were disclosed. The deal allows HealthTab to distribute Abbott's Afinion 2 Analyzer in pharmacies linked with the UK's National Health Service and sets a framework to expand point-of-care testing through community pharmacies, Avricore said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0058720904.USD","SG9999002224.SGD","LU0211331839.USD","ABT","LU0122379950.USD","LU1721429741.USD","LU1061106388.HKD","LU2237957811.SGD","SG9999002232.USD","LU0114720955.EUR","LU1914381329.SGD","LU2133065610.SGD","LU0266013472.USD","IE00B4R5TH58.HKD","PJP","ABT.AU","LU0208291251.USD","LU1721429402.USD","LU0432979614.USD","LU2112291526.USD","LU2324357040.USD","TMED","IE00BJJMRZ35.SGD","LU2211815571.USD","IE00BJT1NW94.SGD","BK4504","LU2237957902.USD","LU0882574055.USD","LU0289739699.SGD","LU2468319806.SGD","SGXZ41872573.SGD","LU0234572021.USD","LU1057294990.SGD","BK4585","LU2089984988.USD","IHI","LU0320765489.SGD","BK4581","IE0009355771.USD","LU0170899867.USD","LU0868494617.USD","LU1691799644.USD","SG9999004303.SGD","SGXZ23171101.USD","IE00BFTCPJ56.SGD","BK4592","BK4568","LU1023059063.AUD","BK4566","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658066995","title":"Abbott Laboratories (ABT) Just Gave Investors Something To Think About","url":"https://stock-news.laohu8.com/highlight/detail?id=2658066995","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658066995?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:26","pubTimestamp":1786436761,"startTime":"0","endTime":"0","summary":"Abbott Laboratories (ABT) is back in focus after beating quarterly estimates and raising its annual profit forecast, pointing investors toward the company’s cancer diagnostics and medical devices businesses as key earnings drivers.\nSee our latest analysis for Abbott Laboratories.\nThe recent earnings beat and guidance raise come alongside a strong 90 day share price return of 28.77% and a 30 day share price return of 15.64%, although the year to date share price return is still down 12.54% and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-laboratories-abt-just-gave-investors-something-to-thi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-laboratories-abt-just-gave-investors-something-to-thi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GXDW","IE0002141913.USD","LU0234572021.USD","LU2112291526.USD","PJP","BK4585","VGFPF","BK4082","BK4211","ISBC","LU1989763690.USD","PMDE","SGXZ23171101.USD","LU0432979614.USD","LU1057294990.SGD","LU1914381329.SGD","RGLO","LU2133065610.SGD","LU2211815571.USD","BK4592","LU1989763427.SGD","LU0114720955.EUR","BMED","BK4566","SG9999002232.USD","DECU","LU1721429741.USD","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4533","ABT.AU","LU0868494617.USD","IHI","LU0122379950.USD","BK4588","FEBU","LU2468319806.SGD","LU2089984988.USD","ABT","VOTE","IE00BJT1NW94.SGD","LU2237957811.SGD","LU0289739699.SGD","LU1023059063.AUD","LU2237957902.USD","TMED","LU0170899867.USD","JOYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654504880","title":"Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2654504880","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654504880?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:50","pubTimestamp":1785156615,"startTime":"0","endTime":"0","summary":"Freenome  and Abbott Laboratories  said Monday that the US Food and Drug Administration approved SimpleScreen CRC, a blood-based colorectal cancer screening test.The companies said the new blood-based screening option is intended for adults 45 and older who are at average risk for the disease.Under the terms of a commercial agreement between Freenome and Abbott, Freenome will receive a $100 million milestone payment from Abbott for the FDA approval, while Abbott will exclusively commercialize the test in the US this fall.Shares of Freenome were up close to 10% pre-bell.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1721429741.USD","LU2324357040.USD","LU1023059063.AUD","LU1721429402.USD","SG9999004303.SGD","BK4592","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1989763690.USD","SGXZ23171101.USD","SG9999002232.USD","LU0882574055.USD","LU2211815571.USD","LU2468319806.SGD","PJP","LU2237957902.USD","BK4585","LABU","SGXZ41872573.SGD","BK4588","IE0009355771.USD","LU0289739699.SGD","FRNM","LU1057294990.SGD","LU0234572021.USD","BK4533","LU0266013472.USD","LU1914381329.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","ABT","BK4568","LU2089984988.USD","LU0114720955.EUR","LU1061106388.HKD","LU1691799644.USD","BK4581","IE00BJT1NW94.SGD","LU0868494617.USD","LU2237957811.SGD","TMED","IHI","LU2112291526.USD","LU1989763427.SGD","IE00BFTCPJ56.SGD","BK4082","IE00B2B36J28.USD","ABT.AU","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653776616","title":"Abbott Stock And 2 Dividend Ideas For Retirement Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2653776616","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653776616?lang=en_us&edition=fundamental","pubTime":"2026-07-24 03:23","pubTimestamp":1784834598,"startTime":"0","endTime":"0","summary":"Social Security reform is back in the headlines, and the bipartisan PROMISE Act has put retirement income security under a brighter spotlight. With projections of a 22% cut to benefits by 2032 if nothing changes, many retirees and near retirees may rethink how much they rely on government programs alone. That is where dividend stocks with consistent payouts and moderate risk scores can play a supporting role. This article looks at 3 dividend stocks from the screener that appear well...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-stock-and-2-dividend-ideas-for-retirement-income","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-stock-and-2-dividend-ideas-for-retirement-income","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4504","SGXZ23171101.USD","IE0009355771.USD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU0058720904.USD","SGXZ41872573.SGD","LU1989763690.USD","LU2133065610.SGD","BK4588","PJP","LU0266013472.USD","LU2112291526.USD","IHI","LU1721429402.USD","LU0868494617.USD","SG9999004303.SGD","SG9999002232.USD","LU0289739699.SGD","ABT","LU2237957811.SGD","VIG","LU1057294990.SGD","IE00BJT1NW94.SGD","LU2211815571.USD","BK4568","LU0170899867.USD","SG9999002224.SGD","IE00B2B36J28.USD","LU2089984988.USD","LU1721429741.USD","BK4533","SPHQ","BK4566","LU2237957902.USD","TMED","IE0002141913.USD","LU1914381329.SGD","LU1989763427.SGD","LU2324357040.USD","BK4082","BK4581","LU0432979614.USD","LU1691799644.USD","LU0234572021.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","ABT.AU","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652828161","title":"Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2652828161","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652828161?lang=en_us&edition=fundamental","pubTime":"2026-07-17 23:00","pubTimestamp":1784300428,"startTime":"0","endTime":"0","summary":"Abbott Laboratories (ABT) beat Q2 expectations, with growth acceleration in the second half of 2026 remaining on track and its longer-term outlook supporting durable growth, RBC Capital Markets said.T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089984988.USD","IHI","LU2237957811.SGD","ABT.AU","IE0009355771.USD","LU2133065610.SGD","BK4568","LU1989763690.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","LU0289739699.SGD","IE00BJJMRZ35.SGD","BK4588","LU2112291526.USD","LU2468319806.SGD","BK4082","LU1691799644.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","ABT","LU0234572021.USD","LU1057294990.SGD","LU2211815571.USD","PJP","LU1914381329.SGD","LU0266013472.USD","LU0122379950.USD","LU1721429402.USD","BK4566","IE00B2B36J28.USD","LU0170899867.USD","LU1023059063.AUD","LU0882574055.USD","LU1061106388.HKD","BK4581","BK4592","BK4585","LU1989763427.SGD","BK4533","SG9999004303.SGD","SG9999002232.USD","LU1721429741.USD","SGXZ23171101.USD","LU0114720955.EUR","LU0868494617.USD","LU2324357040.USD","BK4504","LU2237957902.USD","IE0002141913.USD","SGXZ41872573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651528449","title":"GUIDANCE: (ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.45 to $5.60, vs. FactSet Est of $5.47","url":"https://stock-news.laohu8.com/highlight/detail?id=2651528449","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651528449?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:32","pubTimestamp":1784201562,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ABT) Abbott Laboratories Expects 2026 Adjusted EPS Range $5.45 to $5.60, vs. FactSet Est of $5.47","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABT","ABT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651116911","title":"3 US Healthcare Stocks Investors May Revisit As Inflation Pressures Build","url":"https://stock-news.laohu8.com/highlight/detail?id=2651116911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651116911?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:32","pubTimestamp":1783931562,"startTime":"0","endTime":"0","summary":"With crude and polypropylene costs rising after the Strait of Hormuz closure and fresh U.S. inflation data just ahead, many investors are rethinking how much risk they want to carry. Large cap defensive stocks can sometimes offer a middle ground by balancing exposure to inflation with the financial strength of bigger companies. This article looks at how the recent inflation shock and earnings season backdrop intersect with one U.S. Large-Cap Defensive Stocks screener and identifies 3 stocks...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/3-us-healthcare-stocks-investors-may-revisit-as-inflation-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/3-us-healthcare-stocks-investors-may-revisit-as-inflation-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DFUV","IUS","ARP","CLIX","DIVZ","RMD","CDC","ABT","BSR","CGDV","TEQI","FLV","EES","FXD","HIDV","ISBC","IMCG","HCSG","MDLV","PRVS","SAMT","SYK","ILCV","VTV","XOEX","BAMA","MODL","BKDV","ADPV","RMIF","VXZ","PSC","RHTX","SDOG","REGL","CGUS","BGSX","LGH","MAPP","FT","XLV","RMD.AU","LCG","EQRR","RULE","DECU","CGUI","VOTE","ABT.AU","FEBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650372991","title":"S&P 500 Posts Weekly Gain as Technology, Energy Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2650372991","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650372991?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:55","pubTimestamp":1783716935,"startTime":"0","endTime":"0","summary":"The Standard & Poor's 500 index rose 1.2% this week, lifted by a fresh burst of AI enthusiasm amid geopolitical jitters as Washington and Tehran resumed high-stakes negotiations.The S&P 500 ended Frid","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BKLC","PTLC","CPST","ABT","GSUS","VOOG","GE","MRCP","VOO","SKHYV","UXJA","NFLX","SKHY","XUSP","FEBT","ISSXF","ABT.AU",".SPX","VUG","CGUS","BAC","ALB","SPYM","ANET","SCHG","FELC","CFO","GTLS","ALB.AU","JNJ","GPIX","FLAO","FLCC","PBJL","GBXB","IFF","TSPA","HELO","LGH","META","SPY","UNH","VYM","PTL","HPE","XPAY","OALC","BKR","UOCT","ACLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646787082","title":"How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott (ABT) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2646787082","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646787082?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:17","pubTimestamp":1782386235,"startTime":"0","endTime":"0","summary":"In June 2026, Abbott’s board declared a quarterly dividend of US$0.63 per share, marking the company’s 410th consecutive quarterly payout since 1924, payable on August 17, 2026 to shareholders of record as of July 15, 2026.\nAround the same time, ALZpath announced it had licensed its proprietary pTau217 antibody to Abbott for use in a blood-based Alzheimer’s diagnostic test on the widely deployed Alinity ci-series systems, highlighting Abbott’s push into earlier neurodegenerative disease...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/how-an-alzpath-alzheimers-test-deal-and-dividend-streak-at-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/how-an-alzpath-alzheimers-test-deal-and-dividend-streak-at-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LU0114720955.EUR","LU1691799644.USD","LU1989763690.USD","SG9999002224.SGD","SGXZ41872573.SGD","LU0170899867.USD","LU2324357040.USD","BK4568","LU1023059063.AUD","LU1721429741.USD","LU0266013472.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0234572021.USD","BK4082","LU0882574055.USD","SG9999002232.USD","LU2211815571.USD","LU2237957811.SGD","LU0058720904.USD","LU0289739699.SGD","BK4566","LU0868494617.USD","LU2133065610.SGD","SGXZ23171101.USD","LU1721429402.USD","SG9999004303.SGD","LU0122379950.USD","LU1914381329.SGD","ABT","IE00BFTCPJ56.SGD","BK4504","IE0009355771.USD","IE0002141913.USD","LU2089984988.USD","LU2112291526.USD","ABT.AU","IE00BJJMRZ35.SGD","LU1989763427.SGD","BK4533","IE00B2B36J28.USD","BK4592","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","LU1061106388.HKD","LU2237957902.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645815936","title":"Abbott Laboratories, ALZpath Sign Global Licensing Deal for Alzheimer's Disease Diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2645815936","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645815936?lang=en_us&edition=fundamental","pubTime":"2026-06-24 21:18","pubTimestamp":1782307090,"startTime":"0","endTime":"0","summary":"Abbott Laboratories (ABT) and ALZpath have signed a global licensing deal to incorporate ALZpath's phosphorylated Tau 217 antibody into the development of an in vitro diagnostic test for Alzheimer's d","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0266013472.USD","BK4566","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1721429402.USD","LU1057294990.SGD","LU1914381329.SGD","LU2237957902.USD","IE00B4R5TH58.HKD","LU2133065610.SGD","LU0868494617.USD","BK4504","IE0002141913.USD","BK4581","ABT","BK4082","LU1989763690.USD","IE00B2B36J28.USD","LU2211815571.USD","LU0882574055.USD","LU2089984988.USD","LU2237957811.SGD","LU1721429741.USD","LU1691799644.USD","SG9999004303.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","SGXZ41872573.SGD","BK4533","LU0114720955.EUR","LU0170899867.USD","BK4592","IE0009355771.USD","LU2324357040.USD","LU1061106388.HKD","SGXZ23171101.USD","LU2112291526.USD","LU0058720904.USD","LU0234572021.USD","BK4568","BK4588","LU1023059063.AUD","BK4585","SG9999002232.USD","LU0122379950.USD","ABT.AU","SG9999002224.SGD","LU0289739699.SGD","LU1989763427.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645833449","title":"Abbott Laboratories (ABT) Stock After 33% One-Year Slide Is The Market Overreacting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645833449","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645833449?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:32","pubTimestamp":1782210777,"startTime":"0","endTime":"0","summary":"If you are wondering whether Abbott Laboratories is attractively priced or just a value trap, the stock’s recent performance and current valuation metrics provide some clear signals to consider.\nThe share price recently closed at US$87.83, with returns roughly flat over the last 30 days, up 0.5%, but down 29.3% year to date and down 32.7% over the past year.\nRecent coverage of Abbott Laboratories has focused on how the stock’s weaker one year and multi year returns, down 32.7% over one year...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-laboratories-abt-stock-after-33-one-year-slide-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-laboratories-abt-stock-after-33-one-year-slide-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2237957902.USD","LU2089984988.USD","SG9999002224.SGD","LU2112291526.USD","LU0058720904.USD","BK4533","ABT","LU1061106388.HKD","LU1057294990.SGD","SGXZ23171101.USD","BK4581","BK4588","IE00B2B36J28.USD","LU1989763427.SGD","SG9999004303.SGD","IE00BJJMRZ35.SGD","BK4082","LU0234572021.USD","IE0009355771.USD","LU0170899867.USD","LU1721429741.USD","ABT.AU","LU0882574055.USD","LU2237957811.SGD","SG9999002232.USD","DCF","BK4566","FCF","LU1914381329.SGD","LU1721429402.USD","LU2468319806.SGD","LU0289739699.SGD","LU2211815571.USD","BK4592","LU1989763690.USD","IE0002141913.USD","LU0868494617.USD","BK4568","LU2324357040.USD","LU0122379950.USD","BK4211","BK4504","LU0266013472.USD","LU2133065610.SGD","LU1023059063.AUD","LU0114720955.EUR","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1691799644.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645943080","title":"Abbott Laboratories (ABT) Stock Could Be 24% Below Fair Value Before Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2645943080","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645943080?lang=en_us&edition=fundamental","pubTime":"2026-06-21 10:27","pubTimestamp":1782008845,"startTime":"0","endTime":"0","summary":"Dividend affirmation and earnings catalyst put Abbott Laboratories stock in focus\nRecent commentary on Abbott Laboratories (ABT) has centered on upcoming earnings and Citi highlighting the value of its diversified healthcare businesses, setting the stage for closer attention to the stock.\nThe reaffirmed quarterly dividend and the approaching July 16 earnings report give investors timely reference points as they weigh Abbott Laboratories stock, its current business mix, and expectations around...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-laboratories-abt-stock-could-be-24-below-fair-value-b","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-laboratories-abt-stock-could-be-24-below-fair-value-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ABT.AU","ABT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641769271","title":"Abbott Laboratories (ABT) Is Up 6.4% After European Approval of Dual Glucose‑Ketone Sensors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641769271","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641769271?lang=en_us&edition=fundamental","pubTime":"2026-06-07 21:30","pubTimestamp":1780839029,"startTime":"0","endTime":"0","summary":"In late May and early June 2026, Abbott highlighted new data showing rising, often-missed diabetic ketoacidosis cases and secured CE Mark approval in Europe for Libre Duo and Libre Duo 10 Day, its first-of-its-kind dual glucose‑ketone continuous monitoring systems, while awaiting U.S. FDA clearance.\nThe combination of alarming national trends in DKA-related hospitalizations and Abbott’s dual-analyte sensor positions the company to address a critical gap in diabetes care.\nWe’ll now examine...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-laboratories-abt-is-up-64-after-european-approval-of","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-laboratories-abt-is-up-64-after-european-approval-of","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0882574055.USD","BK4588","BK4082","BK4566","SG9999004303.SGD","LU2324357040.USD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU1989763427.SGD","BK4533","LU2089984988.USD","LU1721429402.USD","LU1914381329.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0114720955.EUR","SGXZ41872573.SGD","LU2112291526.USD","LU2211815571.USD","LU0289739699.SGD","LU1057294990.SGD","LU1989763690.USD","LU1691799644.USD","IE00B2B36J28.USD","BK4592","LU2237957902.USD","SG9999002232.USD","IE00BJT1NW94.SGD","ABT.AU","BK4568","LU1721429741.USD","LU0868494617.USD","BK4504","LU2133065610.SGD","BK4585","LU0266013472.USD","LU0058720904.USD","BK4581","EPV","LU0234572021.USD","LU0122379950.USD","LU0170899867.USD","SGXZ23171101.USD","LU2237957811.SGD","IE0009355771.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","ABT","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640290460","title":"Insulet Rolls Out Omnipod 5 With Enhanced Algorithm, Abbott Libre 3 Plus Compatibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2640290460","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640290460?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:35","pubTimestamp":1780490144,"startTime":"0","endTime":"0","summary":"Insulet  said Wednesday that it has begun rolling out algorithm enhancements for its Omnipod 5 Automated Insulin Delivery system following clearance from the US Food and Drug Administration.The company said Omnipod 5 is now compatible with Abbott's  Libre 3 Plus sensor in the US, providing users with additional continuous glucose monitoring options and allowing caregiver monitoring through the LibreLinkUp app.The update introduces a new 100 mg/dL Target Glucose setting and helps keep users in Automated Mode with fewer interruptions even during prolonged high-glucose events, the company said.The enhancements will be delivered via over-the-air software updates as compatible Pods become available through US retail channels, Insulet added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1989763690.USD","BK4592","BK4551","LU1721429402.USD","LU1084165304.USD","LU1721429741.USD","LU2065171311.SGD","BK4585","LU1119994496.HKD","BK4082","LU0868494617.USD","LU2237957811.SGD","ABT","PODD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4504","IE00BFTCPJ56.SGD","LU0170899867.USD","LU0122379950.USD","ABT.AU","IE0002141913.USD","BK4588","LU0058720904.USD","LU0234572021.USD","LU2112291526.USD","LU2065170008.USD","BK4533","LU0266013472.USD","IE00B4R5TH58.HKD","LU0728928796.USD","SG9999002224.SGD","SGXZ23171101.USD","LU1691799644.USD","LU2468319806.SGD","LU2237957902.USD","SG9999004303.SGD","IE00B2B36J28.USD","BK4566","LU2211815571.USD","SGXZ41872573.SGD","BK4568","LU2133065610.SGD","LU0882574055.USD","LU1914381329.SGD","LU1261432733.SGD","LU1061106388.HKD","LU1057294990.SGD","LU2065171402.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640947420","title":"Is Abbott Laboratories (ABT) Now Attractive After A 33% One Year Share Price Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2640947420","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640947420?lang=en_us&edition=fundamental","pubTime":"2026-06-03 01:22","pubTimestamp":1780420934,"startTime":"0","endTime":"0","summary":"Wondering whether Abbott Laboratories at US$87.78 is starting to look interesting on valuation, or if the market still sees more downside risk than upside.\nThe stock is up 0.4% over the last week but down 1.9% over the last 30 days, with year to date and 1 year returns declining 29.3% and 32.9% respectively, which puts recent moves in sharp contrast to longer term performance.\nThese returns have kept Abbott Laboratories in focus alongside ongoing sector wide interest in healthcare companies,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/is-abbott-laboratories-abt-now-attractive-after-a-33-one-yea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/is-abbott-laboratories-abt-now-attractive-after-a-33-one-yea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BJT1NW94.SGD","LU1914381329.SGD","LU1691799644.USD","BK4533","SG9999002224.SGD","LU2089984988.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU1989763690.USD","LU0882574055.USD","LU0058720904.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU1989763427.SGD","IE0002141913.USD","BK4566","SGXZ23171101.USD","LU0114720955.EUR","LU0266013472.USD","LU0170899867.USD","SG9999004303.SGD","LU1721429741.USD","LU2468319806.SGD","BK4504","LU1061106388.HKD","SG9999002232.USD","LU2237957902.USD","BK4592","ABT.AU","BK4581","LU2237957811.SGD","LU2133065610.SGD","DCF","LU0289739699.SGD","BK4568","SGXZ41872573.SGD","IE00B2B36J28.USD","BK4082","ABT","LU1057294990.SGD","LU2112291526.USD","LU2211815571.USD","LU0868494617.USD","LU1721429402.USD","BK4585","LU0234572021.USD","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635761066","title":"Assessing Abbott Laboratories (ABT) Valuation After Nutrition Setbacks Legal Uncertainty And Softer Analyst Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2635761066","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635761066?lang=en_us&edition=fundamental","pubTime":"2026-05-16 23:38","pubTimestamp":1778945881,"startTime":"0","endTime":"0","summary":"Abbott Laboratories (ABT) is drawing fresh scrutiny after sales declines in its Nutrition business, new product launches and pricing moves, and early signs of recovering volumes, all while analysts grow more cautious on the stock.\nSee our latest analysis for Abbott Laboratories.\nThe share price has come under pressure despite the Exact Sciences acquisition and commentary around legal risks. The stock is down 16.83% on a 1 month share price return, and the 1 year total shareholder return has...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/assessing-abbott-laboratories-abt-valuation-after-nutrition","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/assessing-abbott-laboratories-abt-valuation-after-nutrition","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4566","BK4504","BK4592","IE0009355771.USD","IE00BJT1NW94.SGD","LU2211815571.USD","SGXZ41872573.SGD","LU0266013472.USD","LU1061106388.HKD","LU0122379950.USD","BK4533","BK4082","BK4568","LU0170899867.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU0868494617.USD","LU2133065610.SGD","SGXZ23171101.USD","BK4585","LU1057294990.SGD","LU2112291526.USD","ABT.AU","SG9999004303.SGD","LU0114720955.EUR","SG9999002232.USD","LU1989763427.SGD","SG9999002224.SGD","LU2324357040.USD","LU2089984988.USD","LU1691799644.USD","LU0289739699.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0234572021.USD","LU1721429741.USD","LU0058720904.USD","LU2468319806.SGD","BK4588","LU1914381329.SGD","LU1989763690.USD","LU1721429402.USD","ABT","LU2237957902.USD","LU2237957811.SGD","LU1023059063.AUD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635062227","title":"Exact Sciences Deal and Legal Pressures Might Change The Case For Investing In Abbott (ABT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635062227","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635062227?lang=en_us&edition=fundamental","pubTime":"2026-05-15 13:48","pubTimestamp":1778824090,"startTime":"0","endTime":"0","summary":"In recent months, Abbott Laboratories reported Q1 2026 results that modestly exceeded sales and earnings expectations, closed its approximately US$21.00 billion acquisition of Exact Sciences to expand in cancer diagnostics, and continued to contend with extensive infant formula-related litigation and a securities class action. \nAt the same time, the company’s decade-high dividend yield, long record of consecutive quarterly payouts, and growing medical devices footprint contrast with...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/exact-sciences-deal-and-legal-pressures-might-change-the-cas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/exact-sciences-deal-and-legal-pressures-might-change-the-cas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1023059063.AUD","LU1861559042.SGD","LU1861558580.USD","EXAS","IE00B4R5TH58.HKD","BK4585","SGXZ23171101.USD","SG9999004303.SGD","BK4581","BK4504","LU1989763690.USD","LU2089984988.USD","BK4568","LU2324357040.USD","IE00BFTCPJ56.SGD","LU1989763427.SGD","LU0122379950.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","BK4566","LU2133065610.SGD","BK4082","ABT.AU","LU2211815571.USD","LU1061106388.HKD","SG9999002232.USD","SGXZ41872573.SGD","LU0170899867.USD","LU1914381329.SGD","LU0868494617.USD","LU2237957902.USD","BK4548","LU0234572021.USD","LU0114720955.EUR","IE0009355771.USD","LU1057294990.SGD","ABT","LU1721429741.USD","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","LU1691799644.USD","LU1721429402.USD","LU2112291526.USD","SG9999002224.SGD","BK4592","BK4533","LU0058720904.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925945","title":"Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925945","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925945?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:19","pubTimestamp":1777987149,"startTime":"0","endTime":"0","summary":"Abbott Laboratories  was Smart Insider's stock pick of the week after Chief Financial Officer Philip Boudreau bought $1.1 million worth of company shares at $91.93 apiece on April 23.The CFO owned $6.5 million in stock and more than 200,000 options before the recent transaction, making it \"unlikely\" that he was under \"pressure\" to make \"such a large purchase,\" Smart Insider said in a Tuesday note.Smart Insider renewed the stock +1, or strong positive signal, on April 28.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2211815571.USD","BK4533","LU1023059063.AUD","SG9999002232.USD","ABT.AU","BK4581","IE00BJJMRZ35.SGD","LU1914381329.SGD","LU1989763690.USD","LU1691799644.USD","LU0170899867.USD","BK4585","SGXZ23171101.USD","LU2133065610.SGD","BK4588","LU2237957902.USD","IE00BJT1NW94.SGD","LU2237957811.SGD","IE0002141913.USD","LU2112291526.USD","LU0882574055.USD","LU1057294990.SGD","SG9999002224.SGD","SGXZ41872573.SGD","BK4566","LU0266013472.USD","LU0289739699.SGD","LU2324357040.USD","BK4504","LU2089984988.USD","IE0009355771.USD","LU0058720904.USD","LU0868494617.USD","SG9999004303.SGD","BK4568","LU1721429741.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0234572021.USD","LU1989763427.SGD","LU0122379950.USD","LU1721429402.USD","BK4592","ABT","LU1061106388.HKD","LU0114720955.EUR","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630133550","title":"Assessing Abbott (ABT) Valuation After New Cardiac Trial Results And Recent Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2630133550","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630133550?lang=en_us&edition=fundamental","pubTime":"2026-04-27 01:07","pubTimestamp":1777223276,"startTime":"0","endTime":"0","summary":"Fresh late breaking clinical data on Abbott Laboratories (ABT) pulsed field ablation and conduction system pacing platforms, including FlexPulse IDE and ASCEND CSP IDE, has put the company’s cardiac device capabilities firmly in focus for investors.\nSee our latest analysis for Abbott Laboratories.\nDespite the strong cardiology data, Abbott’s recent news flow also includes a large ESOP related shelf registration and mixed first quarter results, alongside a downgrade from Daiwa. The share price...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/assessing-abbott-abt-valuation-after-new-cardiac-trial-resul","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/assessing-abbott-abt-valuation-after-new-cardiac-trial-resul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4568","BK4592","IE00B4R5TH58.HKD","LU2237957811.SGD","SGXZ23171101.USD","LU1721429741.USD","LU0170899867.USD","BK4585","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4504","BK4082","LU0868494617.USD","LU1691799644.USD","SGXZ41872573.SGD","SG9999004303.SGD","LU0058720904.USD","SG9999002232.USD","LU2468319806.SGD","IE0002141913.USD","BK4588","LU0122379950.USD","LU1023059063.AUD","LU2112291526.USD","LU0882574055.USD","ABT","LU2324357040.USD","LU0289739699.SGD","LU1989763427.SGD","LU1989763690.USD","LU0114720955.EUR","LU1057294990.SGD","BK4533","ABT.AU","IE00B2B36J28.USD","LU2089984988.USD","BK4581","LU0234572021.USD","LU1721429402.USD","LU2237957902.USD","LU2211815571.USD","LU2133065610.SGD","IE00BJT1NW94.SGD","BK4566","IE00BJJMRZ35.SGD","LU1914381329.SGD","SG9999002224.SGD","LU0266013472.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628675227","title":"Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2628675227","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628675227?lang=en_us&edition=fundamental","pubTime":"2026-04-19 22:04","pubTimestamp":1776607493,"startTime":"0","endTime":"0","summary":"Why Abbott Laboratories (ABT) is on investors’ radar\nAbbott Laboratories (ABT) is drawing attention after a period of weaker share performance, with the stock showing negative returns over the past year and past 3 months despite sizeable global healthcare operations.\nSee our latest analysis for Abbott Laboratories.\nAt a share price of $96.81, Abbott’s recent trading has been weak, with a 30 day share price return of 8.2% and a 1 year total shareholder return decline of 24.58%, pointing to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/assessing-abbott-laboratories-abt-valuation-after-recent-sha-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/assessing-abbott-laboratories-abt-valuation-after-recent-sha-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2237957902.USD","SGXZ41872573.SGD","LU1023059063.AUD","LU2237957811.SGD","BK4533","BK4566","IE0002141913.USD","SG9999002232.USD","SGXZ23171101.USD","LU1691799644.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","BK4082","LU1989763690.USD","LU2468319806.SGD","SG9999004303.SGD","BK4568","LU1914381329.SGD","LU1061106388.HKD","SG9999002224.SGD","IE00B2B36J28.USD","ABT.AU","IE00BFTCPJ56.SGD","BK4504","IE0009355771.USD","ABT","BK4588","IE00B4R5TH58.HKD","BK4585","LU0882574055.USD","LU2089984988.USD","BK4592","LU1057294990.SGD","LU0289739699.SGD","LU0266013472.USD","LU1721429741.USD","LU2133065610.SGD","LU2211815571.USD","LU0170899867.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2112291526.USD","LU0122379950.USD","LU1721429402.USD","LU1989763427.SGD","LU0114720955.EUR","LU0868494617.USD","LU2324357040.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}